Journey Medical CorporationDERMNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P82
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 25.57% |
| Q2 2025 | -13.26% |
| Q1 2025 | 5.16% |
| Q4 2024 | 70.28% |
| Q3 2024 | -5.83% |
| Q2 2024 | -13.82% |
| Q1 2024 | -37.76% |
| Q4 2023 | 11.63% |
| Q3 2023 | 339619.35% |
| Q2 2023 | -99.93% |
| Q1 2023 | -56.08% |
| Q4 2022 | -35.55% |
| Q3 2022 | -25.44% |
| Q2 2022 | -16.69% |
| Q1 2022 | -24.71% |
| Q4 2021 | 348.66% |
| Q3 2021 | -1372.86% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q3 2019 | -78.09% |
| Q2 2019 | -29.11% |
| Q1 2019 | 898.93% |
| Q4 2018 | -116.74% |
| Q3 2018 | -42.25% |
| Q2 2018 | -12.06% |
| Q1 2018 | -14.55% |
| Q4 2017 | -24.70% |
| Q3 2017 | -46.64% |
| Q2 2017 | -8.07% |
| Q1 2017 | 63.76% |
| Q4 2016 | -1.39% |
| Q3 2016 | -7.40% |
| Q2 2016 | 69.47% |
| Q1 2016 | -13.81% |
| Q4 2015 | -13.63% |
| Q3 2015 | 71.53% |